Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoresistance”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Post-approval studies (Phase 4)Study completedNCT00559676
What this trial is testing

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Hospital Regional Universitaire de Limoges 200
Not applicableStudy completedNCT05490407
What this trial is testing

Role of the ATP7A Transporter in Ovarian Cancer

Who this might be right for
Gynecologic CancerOvarian CancerHigh Grade Serous Carcinoma+1 more
University Medical Centre Ljubljana 40
Not applicableActive Not RecruitingNCT06642506
What this trial is testing

Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

Who this might be right for
Esophagus AdenocarcinomaEsophagus CancerMetabolome+5 more
Ludwig-Maximilians - University of Munich 20
Testing effectiveness (Phase 2)Looking for participantsNCT05082519
What this trial is testing

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaObesity
Etan Orgel 240
Not applicableStudy completedNCT01577511
What this trial is testing

Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer

Who this might be right for
Colorectal Neoplasms
Centre Hospitalier Universitaire de Nīmes 60
Not applicableUnknownNCT02898857
What this trial is testing

Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
University Hospital, Montpellier 18
Not applicableUnknownNCT02758652
What this trial is testing

Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tampere University Hospital 160
Not applicableUnknownNCT01889407
What this trial is testing

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 94
Not applicableStudy completedNCT02878122
What this trial is testing

Study of Predictive Factors of Chemoresistance in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Rennes University Hospital 13
Not applicableStudy completedNCT06657755
What this trial is testing

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Lanzhou University Second Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218524
What this trial is testing

The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

Who this might be right for
Glioblastoma Multiforme
Southern Medical University, China 200
Not applicableUnknownNCT03488901
What this trial is testing

Chemoresistance of Trophoblastic Tumors

Who this might be right for
Trophoblastic Tumor
Hospices Civils de Lyon 72
Not applicableStudy completedNCT03672682
What this trial is testing

SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers?

Who this might be right for
DLBCL
Rennes University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT03234595
What this trial is testing

A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma

Who this might be right for
Recurrent GBM
Everfront Biotech Co., Ltd. 22
Testing effectiveness (Phase 2)UnknownNCT00496795
What this trial is testing

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer

Who this might be right for
Stage III Breast Cancer AJCC V7
University of Bergen 100
Not applicableUnknownNCT06348693
What this trial is testing

Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness

Who this might be right for
GlioblastomaGliomaGlioma Glioblastoma Multiforme
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 400
Not applicableStudy completedNCT00551798
What this trial is testing

Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade

Who this might be right for
Hodgkin's DiseaseMalignant Lymphomas High GradeChemoresistance
University Hospital, Limoges 90
Not applicableStudy completedNCT00965276
What this trial is testing

Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 2,500
Next Page